低级别癫痫相关肿瘤中CD34表达与临床病理特征的关系
该回顾性研究纳入2009年1月至2015年6月在意大利8家癫痫外科中心接受手术的187例低级别癫痫相关肿瘤患者,分析CD34表达与人口学、临床及病理特征的关系。95例(50.8%)CD34阳性;多因素分析显示肿瘤类型与癫痫病程独立相关,节细胞胶质瘤和多形性黄色星形细胞瘤的比值比分别为9.2和10.4,癫痫病程>10年者比值比为2.8。
要点
- 187例中95例(50.8%)CD34阳性。
- 节细胞胶质瘤和多形性黄色星形细胞瘤与CD34阳性关联最强,比值比分别为9.2和10.4。
- 癫痫病程>10年者CD34表达可能性更高,比值比2.8。
核心结论
- CD34表达有望成为低级别癫痫相关肿瘤患者有用的生物分子标志物,并显示与临床病理特征相关。
- 本研究证实CD34表达与肿瘤类型的关联,并显示癫痫病程较长患者CD34表达概率显著更高,且独立于组织学。
研究设计与样本
- 回顾性研究,纳入2009年1月至2015年6月在意大利8家癫痫外科中心接受手术的187例低级别癫痫相关肿瘤患者。
- 所有病例按世界卫生组织中枢神经系统肿瘤分类进行组织学诊断,采用单因素和多因素分析识别与CD34表达相关的变量。
主要发现
- 187例患者中95例(50.8%)为CD34阳性。
- 多因素分析显示肿瘤类型和癫痫病程与CD34表达独立相关。
- 与胚胎发育不良性神经上皮肿瘤相比,节细胞胶质瘤和多形性黄色星形细胞瘤与CD34阳性的关联最强,比值比分别为9.2和10.4。
- 与癫痫病程<2年者相比,癫痫病程>10年者显示CD34表达的可能性显著更高,比值比为2.8。
- 单因素分析显示CD34表达似乎与手术时年龄较大、抗癫痫药物使用较多和女性显著相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To analyze relationships between CD34 expression and several demographic, clinical, and pathologic features in patients with histopathologic evidence of low-grade epilepsy-associated tumors who underwent epilepsy surgery. METHODS: A retrospective study enrolling 187 patients with low-grade epilepsy-associated tumors who underwent surgery between January 2009 and June 2015 at 8 Italian epilepsy surgery centers was conducted. All cases were histologically diagnosed according to the World Health Organization classification of central nervous system tumors. Univariate and multivariate analyses were performed to identify variables associated with CD34 expression. RESULTS: Of 187 patients, 95 (50.8%) were CD34 positive. Tumor type and duration of epilepsy were independently associated with CD34 expression on multivariate analysis. Ganglioglioma and pleomorphic xanthoastrocytoma were the histologic types with the strongest association with CD34 positivity with an odds ratio of 9.2 and 10.4, respectively, compared with dysembryoplastic neuroepithelial tumors. Patients with a duration of epilepsy >10 years had a significantly greater likelihood to show CD34 expression, with an odds ratio of 2.8 compared with patients with a duration of epilepsy <2 years. On univariate analysis, CD34 expression appeared to be significantly related to older age at surgery, higher antiepileptic drug intake, and female sex. CONCLUSIONS: CD34 expression holds promise as a useful biomolecular marker for patients with low-grade epilepsy-associated tumors with evidence of a link with clinicopathologic features. This study confirmed the association between CD34 expression and tumor type and demonstrated a significantly higher probability of CD34 expression in patients with longer duration of epilepsy, independent of histology.
引用
- Giulioni M, Marucci G, Cossu M, et al. CD34 Expression in Low-Grade Epilepsy-Associated Tumors: Relationships with Clinicopathologic Features. World Neurosurg. 2018. PMID: 30308344. doi:10.1016/j.wneu.2018.09.212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。